-
Something wrong with this record ?
Renal sympathetic denervation improves cardiac dysfunction in rats with chronic pressure overload
Z. Z. Li, H. Jiang, D. Chen, Q. Liu, J. Geng, J. Q. Guo, R. H. Sun, G. Q. Zhu, Q. J. Shan
Language English Country Czech Republic
Document type Journal Article, Research Support, Non-U.S. Gov't
NLK
Directory of Open Access Journals
from 1991
Free Medical Journals
from 1998
ProQuest Central
from 2005-01-01
Medline Complete (EBSCOhost)
from 2006-01-01
Nursing & Allied Health Database (ProQuest)
from 2005-01-01
Health & Medicine (ProQuest)
from 2005-01-01
ROAD: Directory of Open Access Scholarly Resources
from 1998
- MeSH
- Chronic Disease MeSH
- Hypertrophy, Left Ventricular metabolism physiopathology surgery MeSH
- Myocytes, Cardiac pathology physiology MeSH
- Rats MeSH
- Kidney innervation surgery MeSH
- Rats, Sprague-Dawley MeSH
- Renin-Angiotensin System physiology MeSH
- Heart Failure metabolism physiopathology surgery MeSH
- Sympathectomy trends MeSH
- Sympathetic Nervous System pathology physiology MeSH
- Animals MeSH
- Check Tag
- Rats MeSH
- Male MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
Varied causative and risk factors can lead to cardiac dysfunction. Cardiac dysfunction often evolves into heart failure by cardiac remodeling due to autonomic nervous system disturbance and neurohumoral abnormalities, even if the detriment factors are removed. Renal sympathetic nerve activity plays a pivotal regulatory role in neurohumoral mechanisms. The present study was designed to determine the therapeutic effects of renal sympathetic denervation (RSD) on cardiac dysfunction, fibrosis, and neurohumoral response in transverse aortic constriction (TAC) rats with chronic pressure overload. The present study demonstrated that RSD attenuated myocardial fibrosis and hypertrophy, and structural remodeling of the left atrium and ventricle, up-regulated cardiac beta adrenoceptor (beta-AR, including beta(1)AR and beta(2)AR) and sarco-endoplasmic reticulum Ca(2+)-ATPase (SERCA) while down-regulated angiotensin II type 1 receptor (AT(1)R), and decreased plasma B-type natriuretic peptide (BNP), norepinephrine (NE), angiotensin II (Ang II), and arginine vasopressin (AVP) levels in TAC rats with chronic pressure overload. We conclude that RSD attenuates myocardial fibrosis, the left atrial enlargement, and the left ventricular wall hypertrophy; inhibits the overdrive of the sympathetic nervous system (SNS), renin-angiotensin-aldosterone system (RAAS), and AVP system in TAC rats with chronic pressure overload. RSD could be a promising non-pharmacological approach to control the progression of cardiac dysfunction.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc16031098
- 003
- CZ-PrNML
- 005
- 20161111143315.0
- 007
- ta
- 008
- 161101s2015 xr ad f 000 0|ENG||
- 009
- AR
- 024 7_
- $a 10.33549/physiolres.932912 $2 doi
- 035 __
- $a (PubMed)25804096
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a ENG
- 044 __
- $a xr
- 100 1_
- $a Li, Z.-Z. $u Cardiovascular Department, First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China,
- 245 10
- $a Renal sympathetic denervation improves cardiac dysfunction in rats with chronic pressure overload / $c Z. Z. Li, H. Jiang, D. Chen, Q. Liu, J. Geng, J. Q. Guo, R. H. Sun, G. Q. Zhu, Q. J. Shan
- 520 9_
- $a Varied causative and risk factors can lead to cardiac dysfunction. Cardiac dysfunction often evolves into heart failure by cardiac remodeling due to autonomic nervous system disturbance and neurohumoral abnormalities, even if the detriment factors are removed. Renal sympathetic nerve activity plays a pivotal regulatory role in neurohumoral mechanisms. The present study was designed to determine the therapeutic effects of renal sympathetic denervation (RSD) on cardiac dysfunction, fibrosis, and neurohumoral response in transverse aortic constriction (TAC) rats with chronic pressure overload. The present study demonstrated that RSD attenuated myocardial fibrosis and hypertrophy, and structural remodeling of the left atrium and ventricle, up-regulated cardiac beta adrenoceptor (beta-AR, including beta(1)AR and beta(2)AR) and sarco-endoplasmic reticulum Ca(2+)-ATPase (SERCA) while down-regulated angiotensin II type 1 receptor (AT(1)R), and decreased plasma B-type natriuretic peptide (BNP), norepinephrine (NE), angiotensin II (Ang II), and arginine vasopressin (AVP) levels in TAC rats with chronic pressure overload. We conclude that RSD attenuates myocardial fibrosis, the left atrial enlargement, and the left ventricular wall hypertrophy; inhibits the overdrive of the sympathetic nervous system (SNS), renin-angiotensin-aldosterone system (RAAS), and AVP system in TAC rats with chronic pressure overload. RSD could be a promising non-pharmacological approach to control the progression of cardiac dysfunction.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a chronická nemoc $7 D002908
- 650 _2
- $a srdeční selhání $x metabolismus $x patofyziologie $x chirurgie $7 D006333
- 650 _2
- $a hypertrofie levé komory srdeční $x metabolismus $x patofyziologie $x chirurgie $7 D017379
- 650 _2
- $a ledviny $x inervace $x chirurgie $7 D007668
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a kardiomyocyty $x patologie $x fyziologie $7 D032383
- 650 _2
- $a krysa rodu Rattus $7 D051381
- 650 _2
- $a potkani Sprague-Dawley $7 D017207
- 650 _2
- $a renin-angiotensin systém $x fyziologie $7 D012084
- 650 _2
- $a sympatektomie $x trendy $7 D013562
- 650 _2
- $a sympatický nervový systém $x patologie $x fyziologie $7 D013564
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Jiang, H. $u Cardiovascular Department, First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China,
- 700 1_
- $a Chen, D. $u Key Laboratory of Cardiovascular Disease and Molecular Intervention, Department of Physiology, Nanjing Medical University, Nanjing, Jiangsu, China
- 700 1_
- $a Liu, Q. $u Cardiovascular Department, First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China,
- 700 1_
- $a Geng, J. $u Cardiovascular Department, First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China,
- 700 1_
- $a Guo, J.-Q. $u Cardiovascular Department, First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China,
- 700 1_
- $a Sun, R.-H. $u Cardiovascular Department, First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China,
- 700 1_
- $a Zhu, G.-Q. $u Key Laboratory of Cardiovascular Disease and Molecular Intervention, Department of Physiology, Nanjing Medical University, Nanjing, Jiangsu, China
- 700 1_
- $a Shan, Q.-J. $u Cardiovascular Department, First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China,
- 773 0_
- $w MED00003824 $t Physiological research $x 1802-9973 $g Roč. 64, č. 5 (2015), s. 653-662
- 856 41
- $u http://www.biomed.cas.cz/physiolres/ $y domovská stránka časopisu
- 910 __
- $a ABA008 $b A 4120 $c 266 $y 4 $z 0
- 990 __
- $a 20161101 $b ABA008
- 991 __
- $a 20161110094430 $b ABA008
- 999 __
- $a ok $b bmc $g 1172186 $s 955756
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2015 $b 64 $c 5 $d 653-662 $e 2015Mar24 $i 1802-9973 $m Physiological research $n Physiol. Res. (Print) $x MED00003824
- LZP __
- $b NLK118 $a Pubmed-20161101